Literature DB >> 12498423

Inhibins, activins and follistatin in reproduction.

D M de Kretser1, M P Hedger, K L Loveland, D J Phillips.   

Abstract

The regulation of reproductive processes involves a complex network of communication systems between the brain, endocrine organs, the gonads and other reproductive tissues. Classically, our understanding has focused on the role of endocrine hormones, but more recently interest has also dwelt on the paracrine and autocrine regulation of these cell systems. In this review, the structure and physiology of the inhibins, activins and follistatin are discussed in terms of the evidence supporting their role as endocrine hormones, and how they might function as paracrine factors within the pituitary, gonad and associated tissues. With the advent of more specific techniques and assays for their measurement, the potential of inhibins, activins and follistatin as clinical markers of reproductive function and in the screening of various pathologies is also evaluated.

Mesh:

Substances:

Year:  2002        PMID: 12498423     DOI: 10.1093/humupd/8.6.529

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  41 in total

1.  Confounding effects of hormone replacement therapy in protein biomarker studies.

Authors:  Sharon J Pitteri; Samir M Hanash
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-29       Impact factor: 4.254

2.  Expression of inhibin/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic, and HELLP pregnancies.

Authors:  I Mylonas; B Schiessl; U Jeschke; J Vogl; A Makrigiannakis; C Kuhn; S Schulze; F Kainer; K Friese
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

3.  Alteration in follistatin gene expression detected in prenatally androgenized rats.

Authors:  Marziyeh Salehi Jahromi; Fahimeh Ramezani Tehrani; Jennifer W Hill; Mahsa Noroozzadeh; Maryam Zarkesh; Asghar Ghasemi; Azita Zadeh-Vakili
Journal:  Gynecol Endocrinol       Date:  2017-02-26       Impact factor: 2.260

Review 4.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

5.  Regulation of muscle mass by follistatin and activins.

Authors:  Se-Jin Lee; Yun-Sil Lee; Teresa A Zimmers; Arshia Soleimani; Martin M Matzuk; Kunihiro Tsuchida; Ronald D Cohn; Elisabeth R Barton
Journal:  Mol Endocrinol       Date:  2010-09-01

6.  Enhanced hypothalamic-pituitary sensitivity to estrogen in premenopausal women with diminished ovarian reserve compared with older perimenopausal controls.

Authors:  Katie Zhang; Gohar Zeitlian; Goli Adel; Nanette F Santoro; Lubna Pal
Journal:  Menopause       Date:  2011-08       Impact factor: 2.953

7.  Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle.

Authors:  Ioannis Mylonas; Udo Jeschke; Irmgard Wiest; Anna Hoeing; Julia Vogl; Naim Shabani; Christina Kuhn; Sandra Schulze; Markus S Kupka; Klaus Friese
Journal:  Histochem Cell Biol       Date:  2004-10-12       Impact factor: 4.304

Review 8.  Activins and activin antagonists in hepatocellular carcinoma.

Authors:  Alev Deli; Emanuel Kreidl; Stefan Santifaller; Barbara Trotter; Katja Seir; Walter Berger; Rolf Schulte-Hermann; Chantal Rodgarkia-Dara; Michael Grusch
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 9.  Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.

Authors:  Kristy M Nicks; Daniel S Perrien; Nisreen S Akel; Larry J Suva; Dana Gaddy
Journal:  Mol Cell Endocrinol       Date:  2009-07-15       Impact factor: 4.102

10.  Essential roles of inhibin beta A in mouse epididymal coiling.

Authors:  Jessica Tomaszewski; Avenel Joseph; Denise Archambeault; Humphrey Hung-Chang Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.